GlassScriptPhysician profile
Isabel A Munoz
NPI 1427218809
$2,634.22
in general payments reported to CMS, 2019-2025
25 companies · $767 in 2025
The $767 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $482 · 2023: $353 · 2024: $812 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Education: $10.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.36 |
| Education | $10.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.70 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $275.17 | 2024-2025 | |
| Gm Pharmaceuticals, INC. | $250.00 | 2022 | |
| Abbott Laboratories | $194.66 | 2021-2024 | Freestyle Libre 3, Jot Dx |
| Amgen INC. | $189.71 | 2023-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $174.56 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.15 | 2021-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $158.32 | 2023-2025 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $140.70 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $113.62 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $96.99 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sanofi Pasteur INC. | $89.54 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.95 | 2021-2025 | |
| Phadia US INC. | $74.19 | 2021-2023 | Immunocap |
| Cranial Technologies, INC | $63.88 | 2021-2025 | Doc Band |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $63.77 | 2025 | Breztri |
| Rgh Enterprises LLC | $41.24 | 2025 | |
| Avanos Medical | $38.53 | 2024 | On-Q* Pump and Accessories |
| Acadia Pharmaceuticals INC | $36.50 | 2025 | Daybue |
| Lilly USA, LLC | $27.69 | 2022-2023 | Jardiance |
| Corcept Therapeutics | $25.06 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $22.48 | 2023 | Trelegy Ellipta |
| Paratek Pharmaceuticals, INC. | $16.65 | 2024 | Nuzyra |
| Dexcom, INC. | $14.35 | 2021 | |
| Genentech USA, INC. | $5.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.